No Data
Asymchem Laboratories (002821.SZ): Repurchase completed, with a total expenditure of 0.9996 billion yuan for repurchasing 12.3007 million shares.
On February 18, Gelonghui announced that Asymchem Laboratories (002821.SZ) has cumulatively repurchased 12.300701 million shares of the company through a dedicated repurchase securities account via centralized bidding, accounting for 3.6161% of the company's total A-share capital. The highest Fill Price was 102.00 yuan/share, the lowest Fill Price was 71.65 yuan/share, and the total amount paid was 0.9996 billion yuan (excluding transaction fees). The share repurchase plan has been completed, with the actual repurchase time Range from March 7, 2024, to February 18, 2025.
Brokerage morning meeting highlights: Now is the right time for AI healthcare layout.
In today's Brokerage morning meeting, Sinolink proposed that the layout of AI in healthcare is timely; HTSC expressed a bullish outlook on the product upgrades and commercial breakthroughs of AI applications in China by 2025; China Securities Co.,Ltd. believes that the turning point in the IDC Industry is approaching, and a new cycle is expected to begin.
GTJA: The new paradigm reshapes the drug development landscape, and the cycle of inventory reduction for Active Pharmaceutical Ingredient is approaching its end.
The CXO adjustments are nearing completion, and the Industry is moving towards the development stage 2.0; the API destocking cycle is coming to an end, seizing opportunities for industrial transformation.
Hong Kong stocks fluctuated | CRO Concept stocks continued to surge in the morning, WUXI BIO (02269) and TIGERMED (03347) both rose over 9%.
In the early session, CRO Concept stocks continued to rise. As of the time of writing, WUXI BIO (02269) is up 9.59%, priced at 22.85 HKD; TIGERMED (03347) is up 9.09%, priced at 31.2 HKD; GENSCRIPT BIO (01548) is up 7.22%, priced at 11.88 HKD.
The MSCI Chinese Index has newly included J&T Express (01519) and 8 other Stocks.
Jingwu Financial News | MSCI announced the results of the index review for February. The MSCI Chinese Index added Bestechnic (Shanghai) Co., Ltd., China National Agricultural Development Group, Canadian Solar, J&T Express (01519), Jiangsu Hoperun Software, JinkoSolar, Sichuan Changhong Electric, and Yonghui Superstores, while it removed Anjoy Foods Group, Autobio Diagnostics, Bloomage Biotechnology Corporation Limited, Asymchem Laboratories (06821), Shan Xi Hua Yang Group New Energy, and 20 other Stocks. The adjustments will take effect after the close on February 28.
Hong Kong stock early report on February 12: Contemporary Amperex Technology submitted its IPO application for the Hong Kong stock market, and the Hong Kong General Chamber of Commerce proposed to relax the thresholds for the 'southbound trading' scheme.
① Contemporary Amperex Technology submitted its IPO application for the Hong Kong Stock Exchange. ② The Hong Kong General Chamber of Commerce proposed to relax the investment threshold for 'Southbound Trading' investors. ③ Powell stated that the Federal Reserve has no reason to rush into cutting interest rates. ④ AI has sparked interest in Hong Kong stocks, prompting fund managers to allocate resources to chase this trend.
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Stock Catapults 26% Though Its Price And Business Still Lag The Market
